FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134850869> ?p ?o ?g. }

• W2134850869 endingPage "712" @default.
• W2134850869 startingPage "705" @default.
• W2134850869 abstract "Vasopressin antagonists increase the serum sodium concentration in patients who have euvolemia and hypervolemia with hyponatremia in the short term (</=30 days), but their safety and efficacy with longer term administration is unknown. SALTWATER was a multicenter, open-label extension of the Study of Ascending Levels of Tolvaptan in Hyponatremia (SALT-1 and SALT-2). In total, 111 patients with hyponatremia received oral tolvaptan for a mean follow-up of 701 days, providing 77,369 patient-days of exposure. All patients had hyponatremia at randomization in SALT-1 and SALT-2, and 85% continued to have hyponatremia at entry in SALTWATER. The most common adverse effects attributed to tolvaptan were pollakiuria, thirst, fatigue, dry mouth, polydipsia, and polyuria. Six drug-related adverse effects led to study discontinuation. The increase in serum sodium exceeded the desired 1 mmol/L per h at initiation in five patients. Hypernatremia (>145 mmol/L) led to discontinuation in one patient. Mean serum sodium increased from 130.8 mmol/L at baseline to >135 mmol/L throughout the observation period (P < 0.001 versus baseline at most points). Responses were comparable between patients with euvolemia and those with heart failure but more modest in patients with cirrhosis. In conclusion, prolonged administration of tolvaptan maintains an increased serum sodium with an acceptable margin of safety." @default.
• W2134850869 created "2016-06-24" @default.
• W2134850869 creator A5008684187 @default.
• W2134850869 creator A5009700893 @default.
• W2134850869 creator A5016444110 @default.
• W2134850869 creator A5020007756 @default.
• W2134850869 creator A5033193895 @default.
• W2134850869 creator A5063006329 @default.
• W2134850869 creator A5077062048 @default.
• W2134850869 date "2010-02-25" @default.
• W2134850869 modified "2023-10-02" @default.
• W2134850869 title "Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia" @default.
• W2134850869 cites W1963764569 @default.
• W2134850869 cites W1976870067 @default.
• W2134850869 cites W1986708458 @default.
• W2134850869 cites W2025705989 @default.
• W2134850869 cites W2028115191 @default.
• W2134850869 cites W2037875636 @default.
• W2134850869 cites W2038887241 @default.
• W2134850869 cites W2040609083 @default.
• W2134850869 cites W2050137421 @default.
• W2134850869 cites W2051790791 @default.
• W2134850869 cites W2065336867 @default.
• W2134850869 cites W2065944391 @default.
• W2134850869 cites W2111111770 @default.
• W2134850869 cites W2120040647 @default.
• W2134850869 cites W2135149679 @default.
• W2134850869 cites W2145281681 @default.
• W2134850869 cites W2147439250 @default.
• W2134850869 cites W2163928404 @default.
• W2134850869 cites W2169560588 @default.
• W2134850869 doi "https://doi.org/10.1681/asn.2009080857" @default.
• W2134850869 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2844305" @default.
• W2134850869 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20185637" @default.
• W2134850869 hasPublicationYear "2010" @default.
• W2134850869 type Work @default.
• W2134850869 sameAs 2134850869 @default.
• W2134850869 citedByCount "312" @default.
• W2134850869 countsByYear W21348508692012 @default.
• W2134850869 countsByYear W21348508692013 @default.
• W2134850869 countsByYear W21348508692014 @default.
• W2134850869 countsByYear W21348508692015 @default.
• W2134850869 countsByYear W21348508692016 @default.
• W2134850869 countsByYear W21348508692017 @default.
• W2134850869 countsByYear W21348508692018 @default.
• W2134850869 countsByYear W21348508692019 @default.
• W2134850869 countsByYear W21348508692020 @default.
• W2134850869 countsByYear W21348508692021 @default.
• W2134850869 countsByYear W21348508692022 @default.
• W2134850869 countsByYear W21348508692023 @default.
• W2134850869 crossrefType "journal-article" @default.
• W2134850869 hasAuthorship W2134850869A5008684187 @default.
• W2134850869 hasAuthorship W2134850869A5009700893 @default.
• W2134850869 hasAuthorship W2134850869A5016444110 @default.
• W2134850869 hasAuthorship W2134850869A5020007756 @default.
• W2134850869 hasAuthorship W2134850869A5033193895 @default.
• W2134850869 hasAuthorship W2134850869A5063006329 @default.
• W2134850869 hasAuthorship W2134850869A5077062048 @default.
• W2134850869 hasBestOaLocation W21348508691 @default.
• W2134850869 hasConcept C126322002 @default.
• W2134850869 hasConcept C134018914 @default.
• W2134850869 hasConcept C159641895 @default.
• W2134850869 hasConcept C178790620 @default.
• W2134850869 hasConcept C185592680 @default.
• W2134850869 hasConcept C197934379 @default.
• W2134850869 hasConcept C2776703092 @default.
• W2134850869 hasConcept C2778713406 @default.
• W2134850869 hasConcept C2778715236 @default.
• W2134850869 hasConcept C2778864100 @default.
• W2134850869 hasConcept C2780615674 @default.
• W2134850869 hasConcept C537181965 @default.
• W2134850869 hasConcept C71924100 @default.
• W2134850869 hasConcept C90924648 @default.
• W2134850869 hasConceptScore W2134850869C126322002 @default.
• W2134850869 hasConceptScore W2134850869C134018914 @default.
• W2134850869 hasConceptScore W2134850869C159641895 @default.
• W2134850869 hasConceptScore W2134850869C178790620 @default.
• W2134850869 hasConceptScore W2134850869C185592680 @default.
• W2134850869 hasConceptScore W2134850869C197934379 @default.
• W2134850869 hasConceptScore W2134850869C2776703092 @default.
• W2134850869 hasConceptScore W2134850869C2778713406 @default.
• W2134850869 hasConceptScore W2134850869C2778715236 @default.
• W2134850869 hasConceptScore W2134850869C2778864100 @default.
• W2134850869 hasConceptScore W2134850869C2780615674 @default.
• W2134850869 hasConceptScore W2134850869C537181965 @default.
• W2134850869 hasConceptScore W2134850869C71924100 @default.
• W2134850869 hasConceptScore W2134850869C90924648 @default.
• W2134850869 hasIssue "4" @default.
• W2134850869 hasLocation W21348508691 @default.
• W2134850869 hasLocation W21348508692 @default.
• W2134850869 hasLocation W21348508693 @default.
• W2134850869 hasLocation W21348508694 @default.
• W2134850869 hasOpenAccess W2134850869 @default.
• W2134850869 hasPrimaryLocation W21348508691 @default.
• W2134850869 hasRelatedWork W1992935921 @default.
• W2134850869 hasRelatedWork W2131442876 @default.
• W2134850869 hasRelatedWork W2134850869 @default.
• W2134850869 hasRelatedWork W2395135685 @default.

• next